Drs I.J.H. Vriens
-
Lammers, S. W. M., Geurts, S. M. E., Hermans, K. E. P. E., van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., Honkoop, A. H., van den Berkmortel, F. W. P. J., de Roos, W. K., Imholz, A. L. T., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2024). Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial. Breast Cancer Research and Treatment. Advance online publication. https://doi.org/10.1007/s10549-024-07411-wMeer informative over deze publicatie
-
Lammers, S. W. M., Meegdes, M., Vriens, I. J. H., Voogd, A. C., de Munck, L., van Nijnatten, T. J. A., Keymeulen, K. B. M. I., Tjan-Heijnen, V. C. G., & Geurts, S. M. E. (2024). Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study. ESMO Open, 9(5), Article 103008. https://doi.org/10.1016/j.esmoop.2024.103008Meer informative over deze publicatie
-
Heimovaara, J. H., van Calsteren, K., Lok, C. A. R., Evens, A. M., Hoegl, J., Ferber, A., Fernandes, A., Vriens, I., van Zuylen, L., & Amant, F. (2024). Results of an international survey on the current organization of care for pregnant women with cancer. Acta Obstetricia et Gynecologica Scandinavica, 103(4), 751-756. https://doi.org/10.1111/aogs.14748Meer informative over deze publicatie
-
Welle-Butalid, M. E. T., van Osch, L., van Bree, B. E., Vriens, I. J. H., Derhaag, J. G., de Die-Smulders, C. E. M., Tjan-Heijnen, V. C. G., & van Golde, R. J. T. (2024). Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 293, 27-31. https://doi.org/10.1016/j.ejogrb.2023.12.009Meer informative over deze publicatie
-
Lammers, S. W. M., Thurisch, H., Vriens, I. J. H., Meegdes, M., Engelen, S. M. E., Erdkamp, F. L. G., Dercksen, M. W., Vriens, B. E. P. J., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L. M. H., Peters, N. A. J. B., Tol, J., Heijns, J. B., van de Wouw, A. J., Teeuwen, N. J. A., Geurts, S. M. E., & Tjan-Heijnen, V. C. G. (2024). The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment, 203(2), 339-349. https://doi.org/10.1007/s10549-023-07108-6Meer informative over deze publicatie
-
Lammers, S. W. M., Geurts, S. M. E., Van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., Van Der Sangen, M. J. C., Kroep, J. R., De Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., De Roos, W. K., Linn, S. C., Imholz, A. L. T., Smidt, M. L., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI Cancer Spectrum, 7(6), Article pkad092. https://doi.org/10.1093/jncics/pkad092Meer informative over deze publicatie
-
Tjan-Heijnen, V. C. G., Lammers, S. W. M., Geurts, S. M. E., Vriens, I. J. H., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., de Roos, W. K., Linn, S. C., Imholz, A. L. T., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial. EClinicalMedicine, 58(1), Article 101901. https://doi.org/10.1016/j.eclinm.2023.101901Meer informative over deze publicatie
-
Ibragimova, K. I. E., Geurts, S. M. E., Meegdes, M., Erdkamp, F., Heijns, J. B., Tol, J., Vriens, B. E. P. J., Dercksen, M. W., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L., Peters, N. A. J. B., Teeuwen-Dedroog, N. J. A., Vriens, I. J. H., & Tjan-Heijnen, V. C. G. (2023). Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry. Breast Cancer Research and Treatment, 198(2), 239-251. https://doi.org/10.1007/s10549-022-06832-9Meer informative over deze publicatie
-
Meegdes, M., Ibragimova, K. I. E., Lobbezoo, D. J. A., Vriens, I. J. H., Kooreman, L. F. S., Erdkamp, F. L. G., Dercksen, M. W., Vriens, B. E. P. J., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L. M. H., Tol, J., Heijns, J. B., van de Wouw, A. J., Peters, N. A. J. B., Hochstenbach-Waelen, A., Smidt, M. L., Geurts, S. M. E., & Tjan-Heijnen, V. C. G. (2022). The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment, 192(2), 331-342. https://doi.org/10.1007/s10549-021-06472-5Meer informative over deze publicatie
-
Ibragimova, K. I. E., Geurts, S. M. E., Croes, S., Erdkamp, F., Heijns, J. B., Tol, J., Vriens, B. E. P. J., Aaldering, K. N. A., Dercksen, M. W., Pepels, M. J. A. E., Peters, N. A. J. B., van de Winkel, L., Tilli, D. J. P., Vriens, I. J. H., de Boer, M., & Tjan-Heijnen, V. C. G. (2021). Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry. Breast Cancer Research and Treatment, 188(2), 571-581. https://doi.org/10.1007/s10549-021-06178-8Meer informative over deze publicatie
Drs I.J.H. Vriens
Teacher
Interne Geneeskunde
School for Cardiovascular Diseases
Fac. Health, Medicine and Life Sciences